Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7324 p680-681
6 November 2004

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· New contract
· Medicines management
· Registration examination
· Levothyroxine
· Hiccups
· Prescription pricing
· IT
· Personal control
· Control of entry
· Supermarket pharmacies
· Retention fees
· The Society
· The Journal


Letters to the Editor

Hiccups

Social implications of hiccups are important

From Dr E. K. Rosenbloom, MRPharmS

I read with interest the article (PDF 110K) “Dealing with cases of hiccups” (PJ, 30 October, p647). I have a couple of points to make having reflected on my experience of supporting my daughter in managing her prolonged hiccups for the past three and a half years. The article provides an informative overview but fails to mention two key questions: do the hiccups occur when the person is asleep and what is the impact of hiccups upon the quality of life?

If the hiccups occur when the person is asleep then aetiological factors causing the hiccups should be investigated. If the hiccups are protracted then certainly the person should be reviewed to ensure that that there is no underlying medical condition. If all of the routine investigations do not stop the hiccups episode then the risk benefit equation associated with any interventions should be considered.

After six months my daughter was still hiccuping at a regular rate, sometimes 15 times a minute, and it was “irritating” enough for her to try drug therapies. Chlorpromazine was ineffective but haloperidol did stop the hiccups. It also caused extrapyramidal effects that were far worse than anything described in the textbooks. Explaining to a 16-year-old that the fact that she had no control over the opening of her mouth (and at times sticking out her tongue until it hurt) was a side effect of a drug that she had taken, and that I as a pharmacist had supported, was a professional challenge. This caused her to consider the risks of hiccups and she determined that at present there were none.

It is worth stating that she was assessed at school for the impact of the hiccups upon her ability to take examinations. The impact of the hiccups upon her peers, who were very tolerant of her constant interruptions, was also considered. The only problem that my daughter has ever encountered is the attitude of some teachers who became stressed at the constant interruption and who, on occasions, have requested that she leave the room.

She is continuing her education and will no doubt be reassessed at her university. I am wondering if this comes under the Disabilities Discrimination Act, having lasted for over a year and affected her day-to-day concentration.

I hope that describing a case that focuses on the social implications of treating a long-term condition demonstrates that taking a medical approach may not always solve patients’ problems. She only has another 65 years to go to beat the world record. Watch this space!

E. Karen Rosenbloom
Loughton, Essex

Send your letter to The Editor

Previous Topic (Levothyroxine)
Next Topic (Prescription pricing)

Back to Top


©The Pharmaceutical Journal